Abdullah Haikal

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 8

Top Topics

Molecular Dynamics Simulations

Amyotrophic Lateral Sclerosis

Top Venues

Molecules (Basel, Switzerland)

Journal of enzyme inhibition and medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Wafaa A Ewes, Samar S Tawfik, Aya M Almatary, Mashooq Ahmad Bhat, Hamed W El-Shafey, Ahmed A B Mohamed, Abdullah Haikal, Mohammed Abu El-Magd, Abdullah A Elgazar, Marwa Balaha, Abdelrahman Hamdi
Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study. Molecules (Basel, Switzerland) 29 (13) (2024)
Abdullah Haikal, Ahmed R Ali
Chemical composition and toxicity studies on Lantana camara L. flower essential oil and its in silico binding and pharmacokinetics to superoxide dismutase 1 for amyotrophic lateral sclerosis (ALS) therapy. RSC advances 14 (33) (2024)
Wafaa A Ewes, Samar S Tawfik, Aya M Almatary, Mashooq Ahmad Bhat, Hamed W El-Shafey, Ahmed A B Mohamed, Abdullah Haikal, Mohammed Abu El-Magd, Abdullah A Elgazar, Marwa Balaha, Abdelrahman Hamdi
Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study. Molecules (Basel, Switzerland) 29 (13) (2024)
Wafaa A Ewes, Samar S Tawfik, Aya M Almatary, Mashooq Ahmad Bhat, Hamed W El-Shafey, Ahmed A B Mohamed, Abdullah Haikal, Mohammed Abu El-Magd, Abdullah A Elgazar, Marwa Balaha, Abdelrahman Hamdi
Identification of Benzothiazoles Bearing 1,3,4-Thiadiazole as Antiproliferative Hybrids Targeting VEGFR-2 and BRAF Kinase: Design, Synthesis, BIO Evaluation and In Silico Study. Molecules (Basel, Switzerland) 29 (13) (2024)
Abdullah Haikal, Ahmed R Ali
Chemical composition and toxicity studies on Lantana camara L. flower essential oil and its in silico binding and pharmacokinetics to superoxide dismutase 1 for amyotrophic lateral sclerosis (ALS) therapy. RSC advances 14 (33) (2024)
Abdelrahman Hamdi, Muhammad Yaseen, Wafaa A Ewes, Mashooq Ahmad Bhat, Noha I Ziedan, Hamed W El-Shafey, Ahmed A B Mohamed, Mohamed R Elnagar, Abdullah Haikal, Dina I A Othman, Abdullah A Elgazar, Ahmed H A Abusabaa, Kamal S Abdelrahman, Osama M Soltan, Mostafa M Elbadawi
Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and in silico insights. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Mahmoud Elkazzaz, Amr Ahmed, Yousry Esam-Eldin Abo-Amer, Tamer Hydara, Abdullah Haikal, Dina Abdel Razek Midan, Wafa Ali Eltayb, Xiling Wang, Tomasz M Karpiński, Dalia A Hamza, Basit Jabbar, Israa M Shamkh
In Silico Discovery of GPCRs and GnRHRs as Novel Binding Receptors of SARS-CoV-2 Spike Protein Could Explain Neuroendocrine Disorders in COVID-19. Vaccines 10 (9) (2022)
Israa M Shamkh, Mohammed Al-Majidi, Ahmed Hassen Shntaif, Peter Tan Deng Kai, Ngoc Nh-Pham, Ishrat Rahman, Dalia A Hamza, Mohammad Shahbaz Khan, Maii S Elsharayidi, Eman T Salah, Abdullah Haikal, Modupe Akintomiwa Omoniyi, Mahmoud A Abdalrahman, Tomasz M Karpiński
Nontoxic and Naturally Occurring Active Compounds as Potential Inhibitors of Biological Targets in Liriomyza trifolii . International journal of molecular sciences 23 (21) (2022)